ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,935,712 | +24.7% | 587,257 | +61.3% | 0.01% | +66.7% |
| Q2 2023 | $16,794,272 | +82.7% | 364,064 | +58.8% | 0.00% | 0.0% |
| Q1 2023 | $9,191,441 | -24.9% | 229,213 | -13.2% | 0.00% | 0.0% |
| Q4 2022 | $12,239,876 | +6.9% | 264,189 | -4.5% | 0.00% | 0.0% |
| Q3 2022 | $11,454,000 | +258.6% | 276,589 | +416.7% | 0.00% | – |
| Q2 2022 | $3,194,000 | +44.5% | 53,535 | +75.8% | 0.00% | – |
| Q1 2022 | $2,211,000 | -68.5% | 30,453 | -63.5% | 0.00% | – |
| Q4 2021 | $7,024,000 | +120.8% | 83,522 | +136.8% | 0.00% | – |
| Q3 2021 | $3,181,000 | -80.8% | 35,272 | -79.7% | 0.00% | -100.0% |
| Q2 2021 | $16,535,000 | +6.4% | 173,417 | +27.1% | 0.00% | -33.3% |
| Q1 2021 | $15,534,000 | -73.8% | 136,423 | -68.2% | 0.00% | -25.0% |
| Q4 2020 | $59,354,000 | +2016.8% | 428,778 | +1157.1% | 0.00% | – |
| Q3 2020 | $2,804,000 | -77.0% | 34,108 | -78.1% | 0.00% | -100.0% |
| Q2 2020 | $12,185,000 | +7.3% | 155,782 | -39.0% | 0.00% | -25.0% |
| Q1 2020 | $11,356,000 | +33.6% | 255,589 | +28.4% | 0.00% | +33.3% |
| Q4 2019 | $8,502,000 | +15.8% | 199,047 | +16.0% | 0.00% | +50.0% |
| Q3 2019 | $7,342,000 | -84.7% | 171,623 | -77.3% | 0.00% | -66.7% |
| Q2 2019 | $47,925,000 | +264.6% | 754,711 | +298.3% | 0.01% | +20.0% |
| Q1 2019 | $13,144,000 | +184.7% | 189,500 | +78.5% | 0.01% | +150.0% |
| Q4 2018 | $4,616,000 | -75.7% | 106,170 | -57.3% | 0.00% | -71.4% |
| Q3 2018 | $18,988,000 | -4.7% | 248,734 | -4.0% | 0.01% | 0.0% |
| Q2 2018 | $19,925,000 | +68.3% | 259,200 | +11.6% | 0.01% | +75.0% |
| Q1 2018 | $11,842,000 | -4.6% | 232,236 | -13.3% | 0.00% | -20.0% |
| Q4 2017 | $12,417,000 | +13.5% | 267,728 | +30.3% | 0.01% | 0.0% |
| Q3 2017 | $10,939,000 | +34.8% | 205,400 | +57.3% | 0.01% | +66.7% |
| Q2 2017 | $8,112,000 | -35.7% | 130,600 | -29.9% | 0.00% | -50.0% |
| Q1 2017 | $12,621,000 | -0.5% | 186,200 | +3.2% | 0.01% | 0.0% |
| Q4 2016 | $12,684,000 | +38.9% | 180,394 | +40.2% | 0.01% | +20.0% |
| Q3 2016 | $9,130,000 | +0.2% | 128,700 | -30.9% | 0.01% | 0.0% |
| Q2 2016 | $9,110,000 | -16.8% | 186,263 | +7.6% | 0.01% | -16.7% |
| Q1 2016 | $10,955,000 | +7.5% | 173,040 | +90.5% | 0.01% | +50.0% |
| Q4 2015 | $10,188,000 | +95.6% | 90,814 | +67.9% | 0.00% | +100.0% |
| Q3 2015 | $5,209,000 | -21.3% | 54,084 | -16.4% | 0.00% | 0.0% |
| Q2 2015 | $6,623,000 | +262.9% | 64,679 | +120.0% | 0.00% | – |
| Q1 2015 | $1,825,000 | +173.6% | 29,400 | +93.4% | 0.00% | – |
| Q4 2014 | $667,000 | -78.4% | 15,200 | -72.1% | 0.00% | -100.0% |
| Q3 2014 | $3,085,000 | +337.6% | 54,500 | +247.1% | 0.00% | – |
| Q2 2014 | $705,000 | – | 15,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |